Tonix Pharmaceuticals has entered a research agreement with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm), to study the mechanisms behind the reported benefits of the oxytocin hormone in a mouse model of Prader-Willi syndrome (PWS). Inserm Transfert signed the deal on behalf of Inserm and the Aix-Marseille University in France — […]

Fosgonimeton, an experimental therapy Athira Pharma is developing to treat Alzheimer’s disease, was well-tolerated overall in a Phase 1 clinical trial that included Alzheimer’s patients as well as healthy volunteers. “These encouraging results showed a positive safety and tolerability profile of fosgonimeton across a wide dose range,” Hans Moebius, MD, PhD, Athira’s chief medical officer, said in a press […]

A number of pharmaceutical companies have recently revealed changes to their CEO roles, but other leadership team members have also been announced. BioSpce takes a look at this week’s Movers & Shakers. Ribon Therapeutics – Prakesh Raman was named president and chief executive officer, succeeding Victoria Richon in these roles. Prior to joining Ribon, Raman served […]